Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jan A. J. Schuurkes
Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Effect of Modulation of Serotonergic, Cholinergic, and Nitrergic Pathways on Murine Fundic Size and Compliance Measured by Ultrasonomicrometry
American Journal of Physiology - Gastrointestinal and Liver Physiology
Hepatology
Physiology
Gastroenterology
Related publications
Role of Prucalopride, a Serotonin (5-Ht4) Receptor Agonist, for the Treatment of Chronic Constipation
Clinical and Experimental Gastroenterology
Gastroenterology
Effects of 5-Hydroxytryptamine 2C Receptor Agonist MK212 and 2A Receptor Antagonist MDL100907 on Maternal Behavior in Postpartum Female Rats
Pharmacology Biochemistry and Behavior
Pharmacology
Biochemistry
Clinical Biochemistry
Behavioral Neuroscience
Toxicology
Biological Psychiatry
Cardiovascular Effects of Intravenous Infusions of 5-Hydroxytryptamine in Man
British Journal of Pharmacology and Chemotherapy
5-Ht3 Receptor Antagonism by Anpirtoline, a Mixed 5-Ht1 Receptor Agonist/5-Ht3 Receptor Antagonist
British Journal of Pharmacology
Pharmacology
5-Hydroxytryptamine
Postgraduate Medical Journal
Medicine
Anandamide, an Endogenous Cannabinoid Receptor Ligand, Also Interacts With 5-Hydroxytryptamine (5-Ht) Receptor.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
A Novel Tissue-Selective Β2-Adrenoceptor Agonist With Minimized Cardiovascular Effects, 5-Hob, Attenuates Neuropathic Pain in Mice
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome
Characterization of Binding, Functional Activity and Contractile Responses of the Selective 5‐HT 1F Receptor Agonist Lasmiditan
British Journal of Pharmacology
Pharmacology